Details for New Drug Application (NDA): 011300
✉ Email this page to a colleague
NDA 011300 describes PARAFLEX, which is a drug marketed by Ortho Mcneil Pharm and is included in one NDA. Additional details are available on the PARAFLEX profile page.
The generic ingredient in PARAFLEX is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
The generic ingredient in PARAFLEX is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
Summary for 011300
| Tradename: | PARAFLEX |
| Applicant: | Ortho Mcneil Pharm |
| Ingredient: | chlorzoxazone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011300
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
